THY1 and Parkinson disease: In the Thy1-WTS transgenic mouse model, characterized by pronounced synucleinopathy, we previously showed that CNS-invading CD3+ T lymphocytes contribute to the PD pathogenesis by modulation of CNS myeloid cell activation [57].